1 1 P.B. Clinical Research Limited 07772118 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is Consultancy services Digita Accounts Production Advanced 6.30.9574.0 true 07772118 2023-10-01 2024-09-30 07772118 2024-09-30 07772118 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 07772118 bus:Micro-entities 2023-10-01 2024-09-30 07772118 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 07772118 bus:FilletedAccounts 2023-10-01 2024-09-30 07772118 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 07772118 bus:RegisteredOffice 2023-10-01 2024-09-30 07772118 bus:Director1 2023-10-01 2024-09-30 07772118 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 07772118 bus:Agent1 2023-10-01 2024-09-30 07772118 countries:UnitedKingdom 2023-10-01 2024-09-30 07772118 2022-10-01 2023-09-30 07772118 2023-09-30 07772118 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 xbrli:pure iso4217:GBP

Registration number: 07772118

P.B. Clinical Research Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2024

 

P.B. Clinical Research Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

P.B. Clinical Research Limited

Company Information

Director

Mrs Pippa Bannister

Registered office

Swyllmers
The Lee
Great Missenden
Bucks
HP16 9NA

Accountants

AIMS Accountants for Business 36 Wattleton Road
Beaconsfield
Bucks
HP9 1SE

 

P.B. Clinical Research Limited

(Registration number: 07772118)
Balance Sheet as at 30 September 2024

2024
£

2023
£

Fixed assets

2,968

3,957

Current assets

77,833

138,197

Creditors: Amounts falling due within one year

(11,625)

(21,602)

Net current assets

66,208

116,595

 

69,176

120,552

Capital and reserves

69,176

120,552

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Swyllmers
The Lee
Great Missenden
Bucks
HP16 9NA

These financial statements were authorised for issue by the director on 13 February 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 13 February 2025
 

 

P.B. Clinical Research Limited

(Registration number: 07772118)
Balance Sheet as at 30 September 2024

.........................................
Mrs Pippa Bannister
Director